engleski

Screening for dyslipidemia in children - prevention of premature cardiovascular disease

Dyslipidemia is a major cardiovascular disease risk factor for accelerated atherosclerosis and early clinical manifestations of cardiovascular disease. In childhood, primary dyslipidemia is more common than secondary dyslipidemia, and it is hereditary metabolic disorder of lipoproteins. Given that primary dyslipidemia runs from the child's birth and that there is no symptomatic clinical manifestation, it is important to determine, as early as possible, disorder of the lipid profile in children and relatives, and prevent or reduce the accelerated atherosclerosis and early cardiovascular clinical expression. Using universal screening for dyslipidemia, which should cover as many prepubertal children with proper state of health, we can identify the disorder of lipid profile in children, and slow down or reduce the early clinical manifestations of atherosclerotic cardiovascular disease. The basic therapeutic approach to prevent and control children with dyslipidemia includes practicing healthy eating habits, regular physical activities, limiting sedentary lifestyle and avoiding inhalation of smoke, and use of lipid-altering drugs in indicated cases.

atherosclerosis, cardiovascular disease, children, prevention and treatment, screening for dyslipidemia

nije evidentirano